Catalyst Wire Dossier Catalyst Wire Dossier

GnRH antagonist with add-back therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GnRH antagonist with add-back therapy, covering 2025-09-15 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters [NA]

See pricing